Contrast US processing tool shows malignant liver lesions

Swiss researchers have developed a real-time parametric imaging technique for distinguishing benign from malignant liver lesions easily and noninvasively using contrast-enhanced ultrasound. In its first clinical run, the method delivered high sensitivity and specificity in a patient cohort.

Distinguishing benign from malignant focal liver lesions noninvasively using ultrasound is a key research goal, and is considered the most promising potential use of contrast-enhanced ultrasound.

Click here to read the full article